Wednesday, September 23, 2026. 12 PM-1 PM ET
Roundtable presenters Dr. David Sacks MB, ChB, FRCPath, Chairman, Steering Committee National Glycohemoglobin Standardization Program (NGSP), and Priya Sivaraman, PhD, Senior Technical Product Manager, Tosoh Bioscience
CAP TODAY does not endorse any of the products or services named within. The roundtable is made possible by a special educational grant from Tosoh Bioscience Inc.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, September 24, 2026 11 AM-12 PM CT
This session explores the evolving role of RAS in precision oncology, from the biology of RAS mutations to the expanding landscape of targeted therapies. Through expert presentations, real-world case discussions, and interactive audience polling, participants will examine best practices for RAS biomarker testing across solid tumors, including lung, colorectal, and pancreatic cancers. The session will highlight practical considerations for tissue and liquid biopsy, strategies to address testing gaps, and the importance of multidisciplinary collaboration to ensure timely identification of patients who may benefit from RAS-targeted therapies.
Webinar presenters David Braxton, MD, Chief of Molecular Pathology Services, Hoag Family Cancer Institute & Hoag Memorial Hospital Presbyterian, and Carlos Becerra, MD, Research Director for Medical Oncology, Margaret Given Larkin Endowed Chair for Developmental Cancer Therapeutics, Hoag Memorial Hospital Presbyterian
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from OncoLens and Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, September 30, 2026. 1 PM-1:30 PM ET
Roundtable presenters John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, and Flora Berisha, MS, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson Innovative Medicine, and Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center
CAP TODAY does not endorse any of the products or services named within. The roundtable is made possible by a special educational grant from Pillar Biosciences.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, October 1, 2026 1 PM-2 PM ET
This presentation will explore the value of in-house CGP, offer insights into the benefits and drawbacks of incorporation, and provide information about important practical factors when considering in-house implementation of CGP.
Webinar presenter Allison M. Cushman-Vokoun, MD, PhD, FCAP, Medical Director, Molecular Diagnostics and Personalized Medicine Laboratory, Director, Division of Diagnostic Molecular Pathology and Human Genetics, Henry F. Krous Professor of Pathology, University of Nebraska Medical Center
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Illumina.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, October 20, 2026 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.
Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Roche.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 3, 2026 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.
Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
March 24, 2015—An international multidisciplinary group has published consensus guidelines on the pathologic diagnosis and reporting of intraductal papillary mucinous neoplasms. The group’s nine recommendations aim to “ensure proper communication of salient tumor characteristics to the management teams, accurate comparison of data between analyses, and development of more effective management algorithms.” Read the abstract.
Jan. 29, 2015—Laboratory informatics plays a vital role in helping labs expand their reach and become more involved in patient outcomes. The latest Orchard Software white paper reviews how to evaluate whether a laboratory information system can help carry out that task, and when it is time to look for something new. Read it. According to Orchard, these are some warning signs of an outdated LIS: it is unreliable, difficult to support, lacks satisfactory customer service, lacks key functionality, cannot integrate with
Jan. 26, 2015—MicroRNAs, the small noncoding RNA 18-24 nucleotides in length that post-transcriptionally regulate gene regulation, are taking on a larger role in biomarker discovery, diagnostic development, and therapeutic target development. In this Jan. 27 webinar, a senior scientist at life science firm Promega will discuss a novel chemistry the company developed to simplify and improve the process of isolating MicroRNAs. The presentation begins at 11 a.m. CST. Register.
Jan. 13, 2015—Two articles have been released early online this month by The Archives of Pathology & Laboratory Medicine. One study (abstract | PDF) concludes that traditional diagnostics such as histopathology, acid-fast bacilli smear, and culture should continue to take precedence over AFB PCR in detecting mycobacteria in clinical specimens. The other early release (abstract | PDF) reviews the different immunohistochemical features used for identification, subclassification, prognosis, and sometimes treatment of diffuse large B-cell lymphoma and related lymphomas, based on
Dec. 15, 2014—In a health care environment that has little room for waste, it has become imperative that laboratories take a proactive role in making sure that the best tests are ordered, and interpreted properly, to contribute to the goal of better patient care. A white paper from LIS-maker Orchard Software outlines the new paradigm and offers examples of how to monitor and improve test use.
Dec. 12, 2014—The Archives of Pathology & Laboratory Medicine has published three important articles as early online releases. An editorial (abstract | PDF) asks, “How Will the $1,000 Dollar Genome Meet Reality (and Centers for Medicare & Medicaid Services)?” Meanwhile, a survey (abstract | PDF) of nearly 1,000-plus laboratories provides an update on use of high-risk HPV testing. Finally, the CAP’s Personalized Health Care Committee has published the 2014 Cancer Genomics Resource List (abstract | PDF).
Nov. 24, 2014—An “onslaught” of public and private payer changes to coding, billing, and collections are likely to make life tougher for clinical laboratories next year. The Dark Report is presenting a 90-minute webinar aimed at helping labs maximize the money they generate from testing in 2015. The Dec. 4 webinar’s speakers are: Rina Wolf from Xifin, Tom Scheanwald from APS Medical Billing, and Michelle Miller from Vachette Pathology. Learn more.
Nov. 2, 2014—A recently released white paper, “Augmenting an Enterprise-Wide HIT System with a Best-of-Breed Anatomic Pathology LIS,” explains the “hidden traps” found in enterprise-wide and limited-function pathology laboratory information system products, and discusses EHR vendors that recognize the importance of a best-of-breed anatomic pathology LIS. The white paper, released by NovoPath, also explores how four AP laboratories successfully used a best-of-breed AP-specific lab system and evaluates the pathology LIS as a cornerstone of an AP lab’s growth strategy. Sign
Oct. 6, 2014—Learn how to use acoustic flow cytometry to detect rare events in hematopoietic stem cells from whole blood, spot small particles and multiple fluorescent proteins, and identify immunological cellular subsets using more than 10 parameters in whole blood and mouse splenocytes. This webinar focuses on Life Technologies‘ Attune NxT Acoustic Focusing Cytometer. Watch it now. Registration required.
Sept. 15, 2014—This symposium in San Francisco, Oct. 17-18, will examine a a big data approach to biomarker discovery and clinical assay diagnostic assay development in oncology that Munich-based Definiens is calling tissue phenomics. Speakers include Definiens co-founder and Nobel Laureate Gerd Binnig, PhD. Learn more.
